Navigation Links
Jefferson researcher receives 2010 Pancreatic Cancer Action Network-AACR Career Development Award
Date:4/13/2010

PHILADELPHIA Molecular biologist Jonathan Brody, Ph.D., assistant professor, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, has been awarded a 2010 Pancreatic Cancer Action Network American Association of Cancer Research (AACR) Career Development Award in memory of Skip Viragh. This two-year grant awards $200,000 to Dr. Brody to help support his innovative research in pancreatic cancer. He will receive recognition for his work at the 2010 AACR annual meeting in Washington, D.C. on April 20th.

"As a young pancreatic cancer researcher I have always admired these two top-notch organizations," says Dr. Brody. "To be recognized by them truly is an honor and validates the direction of my research."

This award allows him to produce a body of high-quality data over the next few years as he strives to extend his funding and work with the aid of such agencies as the National Cancer Institute (NCI). Ultimately, Dr. Brody hopes this funding will help translate the work in his laboratory for the benefit of pancreatic cancer patients in the clinical setting.

Dr. Brody will use the funding to build upon his research on a stress-response protein called Hu antigen R (HuR), "activated' in pancreatic tumor cells. Dr. Brody and his team have found that HuR can actually be used to predict the effectiveness of the standard chemotherapy treatment for pancreatic cancer: gemcitabine. Dr. Brody and his team are now seeking a way to activate HuR in patients that show low levels of the protein. "The research is moving into expanding our clinical samples as well as building on pre-clinical, animal models for further exploration," says Dr. Brody. "We are intrigued as to whether other chemotherapeutic agents might also engage this same pathway."

This means that HuR is essentially a biomarker, which we can use to determine up front whether a patient is likely to respond to this treatment or not. The findings of his initial study, of which Dr. Brody was the senior author and Dr. Agnieszka Witkiewicz, assistant professor, Department of Pathology, Anatomy and Cell Biology, closely collaborated on, were first published as a Priority Report in the journal Cancer Research in June 2009; a follow up report is being presented at the American Surgical Association in Chicago this April. Dr. Witkiewicz's involvement and expertise has been critical for this work.

"While the need for scientific and medical breakthroughs in pancreatic cancer research is urgent, there is a major shortage of federal funding for research on this deadly disease," says Julie Fleshman, President and CEO of the Pancreatic Cancer Action Network. "Since 1999, the Pancreatic Cancer Action Network has been working to help fill this critical void. In 2010, we will disburse nearly $2.3 million in funding for research grants. We are excited about this partnership with Dr. Brody and look forward to working with him as we make strides against pancreatic cancer ."

"By improving our understanding of drug metabolism and the molecular diversity that exists within the patient population, this study has important implications for the development of personalized medicine for pancreatic cancer," notes Ms. Fleshman. "The results have the potential to help us learn how to customize treatments for patients to improve outcomes and survival."

One of three Career Development Awards granted to junior faculty at academic and medical institutions this year, Dr. Brody's award is named for the philanthropist and Rydex Investments founder Skip Viragh, who died of pancreatic cancer in 2003.


'/>"/>

Contact: Ed Federico
ed.federico@jefferson.edu
Thomas Jefferson University
Source:Eurekalert  

Related medicine news :

1. Jefferson physician named 2010 Emergency Department Director of the Year
2. Jefferson surgeon receives outstanding performance award from American College Of Surgeons
3. Jefferson neurosurgeon helps draft new treatment guidelines for brain metastases
4. Jefferson awarded multi-million dollar NIH grant
5. Researchers find compound effective in destroying antibiotic-resistant biofilms
6. Boston researchers lead $15 million federal research grant to support advancement of health IT
7. Researchers discover new approach for identifying smokers at highest risk for developing lung cancer
8. Researchers aim for consensus on measuring the impact of visual impairment
9. Researchers Boost Post-Heart Attack Survival in Mice
10. Researchers quantify benefits of minimally invasive removal of hard-to-reach tumors
11. Researchers design self-test for memory disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Jefferson researcher receives 2010 Pancreatic Cancer Action Network-AACR Career Development Award
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, ... relations, content marketing, social media management, corporate communications, SEO and cause marketing, is ... and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding ...
(Date:2/23/2017)... ... 2017 , ... Pink Pig Publishing LLC announces the launch ... the world from different perspectives. By providing a place for people of all ... empathy, and find greater happiness. , "Our approach to structuring content is ...
(Date:2/23/2017)... RI (PRWEB) , ... February 23, 2017 , ... ... today a new partnership with the Rhode Island Consortium for Autism Research and ... an opportunity for children with autism spectrum disorder (ASD) to see films in ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the ... CM-AT in children aged 3-8 with Autism, is now enrolling at three new sites. ... across the United States. , “There are currently no approved drugs that address ...
(Date:2/22/2017)... Setauket, New York (PRWEB) , ... February 22, ... ... main floor entrance and lobby of a new healthcare contact center in Georgia, ... results. , One of the nation’s largest healthcare systems recently invested $51 million ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... On Wednesday, February 22, 2017, US ... of nine sectors finished the trading sessions in green, four ... Major US indices were also mixed at the close of ... slightly down by 0.09%; the Dow Jones Industrial Average edged ... closed at 2,362.82, down 0.11%. This Thursday morning, Stock-Callers.com looks ...
(Date:2/23/2017)... , February 23, 2017 Tillotts ... the Berlin office was opened ... Kritikos . The portfolio includes Entocort ® for ... the treatment of ulcerative colitis, and VistaPrep ® ... the Swiss specialty pharmaceutical company focused on the treatment ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
Breaking Medicine Technology: